Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adrian P Gee

Showing results (11-20 of 90) with videos related to

Pageof 9
Sort By:
Cytotherapy|March 3, 2011
Good manufacturing practice-grade cytotoxic T lymphocytes specific for latent membrane proteins (LMP)-1 and LMP2 for patients with Epstein-Barr virus-associated lymphomaCatherine M Bollard, Stephen Gottschalk, M Helen Huls, et al.
Neurosurgical Focus|March 18, 2008
Cell therapies for traumatic brain injuryMatthew T Harting, James E Baumgartner, Laura L Worth, et al.
Cytotherapy|December 17, 2011
Production of good manufacturing practice-grade cytotoxic T lymphocytes specific for Epstein-Barr virus, cytomegalovirus and adenovirus to prevent or treat viral infections post-allogeneic hematopoietic stem cell transplantUluhan Sili, Ann M Leen, Juan F Vera, et al.
Journal of Virology|October 19, 2007
Identification of hexon-specific CD4 and CD8 T-cell epitopes for vaccine and immunotherapyAnn M Leen, Anne Christin, Mariam Khalil, et al.
Clinical Transplantation|July 11, 2006
Use of cytokine polymorphisms and Epstein-Barr virus viral load to predict development of post-transplant lymphoproliferative disorder in paediatric liver transplant recipientsTimothy C Lee, Barbara Savoldo, Neal R Barshes, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 14, 2009
Rapid transport and infusion of hematopoietic cells is associated with improved outcome after myeloablative therapy and unrelated donor transplantHillard M Lazarus, Fangyu Kan, Sergey Tarima, et al.
Blood|January 31, 2004
Prompt versus preemptive intervention for EBV lymphoproliferative diseaseHans-Joachim Wagner, Yee Chung Cheng, M Helen Huls, et al.
Clinical Transplantation|November 15, 2006
Quantification of a low cellular immune response to aid in identification of pediatric liver transplant recipients at high-risk for EBV infectionTimothy C Lee, John A Goss, Cliona M Rooney, et al.
Frontiers in Cell and Developmental Biology|January 4, 2021
Two Decades of Global Progress in Authorized Advanced Therapy Medicinal Products: An Emerging Revolution in Therapeutic StrategiesRoya Ramezankhani, Shukoofeh Torabi, Neda Minaei, et al.
Cytotherapy|September 15, 2022
Environmental oxygen affects ex vivo growth and proliferation of mesenchymal progenitors by modulating mitogen-activated protein kinase and mammalian target of rapamycin signalingMaria da Graça Cabreira, Xiaohong Wang, Andre Critsinelis, et al.
Pageof 9

Showing results (11-20 of 90) with videos related to

Sort By:
Pageof 9
Cytotherapy|March 3, 2011
Good manufacturing practice-grade cytotoxic T lymphocytes specific for latent membrane proteins (LMP)-1 and LMP2 for patients with Epstein-Barr virus-associated lymphomaCatherine M Bollard, Stephen Gottschalk, M Helen Huls, et al.
Neurosurgical Focus|March 18, 2008
Cell therapies for traumatic brain injuryMatthew T Harting, James E Baumgartner, Laura L Worth, et al.
Cytotherapy|December 17, 2011
Production of good manufacturing practice-grade cytotoxic T lymphocytes specific for Epstein-Barr virus, cytomegalovirus and adenovirus to prevent or treat viral infections post-allogeneic hematopoietic stem cell transplantUluhan Sili, Ann M Leen, Juan F Vera, et al.
Journal of Virology|October 19, 2007
Identification of hexon-specific CD4 and CD8 T-cell epitopes for vaccine and immunotherapyAnn M Leen, Anne Christin, Mariam Khalil, et al.
Clinical Transplantation|July 11, 2006
Use of cytokine polymorphisms and Epstein-Barr virus viral load to predict development of post-transplant lymphoproliferative disorder in paediatric liver transplant recipientsTimothy C Lee, Barbara Savoldo, Neal R Barshes, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 14, 2009
Rapid transport and infusion of hematopoietic cells is associated with improved outcome after myeloablative therapy and unrelated donor transplantHillard M Lazarus, Fangyu Kan, Sergey Tarima, et al.
Blood|January 31, 2004
Prompt versus preemptive intervention for EBV lymphoproliferative diseaseHans-Joachim Wagner, Yee Chung Cheng, M Helen Huls, et al.
Clinical Transplantation|November 15, 2006
Quantification of a low cellular immune response to aid in identification of pediatric liver transplant recipients at high-risk for EBV infectionTimothy C Lee, John A Goss, Cliona M Rooney, et al.
Frontiers in Cell and Developmental Biology|January 4, 2021
Two Decades of Global Progress in Authorized Advanced Therapy Medicinal Products: An Emerging Revolution in Therapeutic StrategiesRoya Ramezankhani, Shukoofeh Torabi, Neda Minaei, et al.
Cytotherapy|September 15, 2022
Environmental oxygen affects ex vivo growth and proliferation of mesenchymal progenitors by modulating mitogen-activated protein kinase and mammalian target of rapamycin signalingMaria da Graça Cabreira, Xiaohong Wang, Andre Critsinelis, et al.
Pageof 9